March 21, 2024
Axios – Diagnostic test debate returns with FDA rule near
The VALID Act and the regulation of diagnostic tests resurfaced at a House Energy and Commerce hearing today that coincided with the FDA finalizing a rule that would give it oversight for four years. The big picture: Trade groups mostly supported Congress taking action on oversight of the tests, with some explicitly endorsing the VALID…
Read More